Integer Holdings (ITGR)
(Delayed Data from NYSE)
$121.11 USD
+0.11 (0.09%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $121.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
0 items in cart
Integer Holdings Corporation [ITGR]
Reports for Purchase
Showing records 21 - 40 ( 311 total )
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Increasingly Confident in End-Market Demand; Raising Price Target to $96
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Company: Integer Holdings Corporation
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Integer Holdings Corporation
Industry: Medical - Instruments
2023 Life Sciences & MedTech Investor Forum: Key Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department